Janssen Cilag International

Haematologic Malignancies and Blood Disorders

Multiple myeloma, relapsed or refractory myeloma, chronic lymphocytic leukemia, small lymphocytic lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia, myelodysplastic neoplasms, and AL amyloidosis are prominent areas of interest, alongside studies in mantle cell lymphoma and other B-cell malignancies.

  • Multiple myeloma and plasma cell disorders
  • B-cell non-Hodgkin lymphoma and CLL/SLL
  • Acute leukemia and myelodysplastic neoplasms

Research also extends to warm autoimmune hemolytic anemia and other haematology-focused conditions.

Oncology in Solid Tumours

The sponsor funds research in non-small cell lung cancer, prostate cancer, urothelial cancer, bladder cancer, colorectal cancer, head and neck squamous cell carcinoma, and other advanced solid tumors, including metastatic and recurrent disease settings.

  • Non-small cell lung cancer
  • Prostate cancer
  • Urothelial and bladder cancers

Additional activity includes studies in gastric cancer, advanced solid tumors, and biomarker-defined tumour populations.

Immune-Mediated and Inflammatory Diseases

Clinical research includes psoriasis, psoriatic arthritis, ulcerative colitis, Crohn’s disease, rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s disease, and idiopathic inflammatory myopathies, with both adult and paediatric populations represented.

  • Psoriasis and psoriatic arthritis
  • Inflammatory bowel disease
  • Systemic autoimmune and rheumatologic disease

Work also covers atopic dermatitis, asthma, and chronic inflammatory demyelinating polyneuropathy.

Neurology, Psychiatry, and Ophthalmology

Janssen Cilag International supports studies in Alzheimer’s disease, major depressive disorder, bipolar depression, myasthenia gravis, chronic inflammatory neuropathies, and stroke prevention, together with ophthalmic research in geographic atrophy and X-linked retinitis pigmentosa.

  • Alzheimer’s disease and cognitive decline
  • Depression and related mood disorders
  • Neuromuscular and retinal disorders

Further interest includes acute suicidal ideation and healthy volunteer studies supporting neurological and psychiatric development.

Cardiovascular, Maternal, Infectious, and Metabolic Conditions

The portfolio also includes atrial fibrillation, acute coronary syndrome, atherothrombotic and thromboembolic disorders, acute ischemic stroke, and metastatic castration-sensitive prostate cancer with cardiovascular-relevant treatment questions, as well as maternal-fetal conditions such as hemolytic disease of the fetus and newborn and fetal and neonatal alloimmune thrombocytopenia.

  • Atrial fibrillation and ischemic stroke
  • Maternal-fetal haematology
  • Hepatitis B and hepatitis D co-infection

Research activity also includes tuberculosis, renal impairment, and healthy adult participant studies relevant to drug disposition and clinical use.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of erdafitinib treatment for adults and adolescents with advanced solid tumors having FGFR gene changes

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Spain
  • Study on Skin Care for Patients with Advanced EGFR-Mutated Lung Cancer Treated with Amivantamab and Lazertinib

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France Germany Spain
  • Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Belgium Denmark France Germany Greece Italy +4
  • Study on the Safety and Effectiveness of Erdafitinib Alone or with Cetrelimab and Chemotherapy for Patients with Metastatic or Advanced Urothelial Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Spain
  • Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Bulgaria Czechia Denmark France Germany +7
  • Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Metastatic Prostate Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Czechia France Germany Hungary Italy +4